ATAD1 and malaria: Current malaria vaccine development approaches are based on inducing high levels of protective immunity against sporozoites (PfCSP),2,4 blood stage (Rh5 and MSP1)16,41 and gametocyte stage (Pfs48/45, Pfs25, and Pfs230).42